MET signaling drives acquired resistance to erdafitinib in muscle-invasive bladder cancer cells.
MET信号通路驱动肌层浸润性膀胱癌细胞对厄达替尼产生获得性耐药性。
期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-08221-8
Makabe Syunta, Hoshi Kyoka, Kaneko Hiromi, Masuishi Yusuke, Yaginuma Kei, Meguro Satoru, Onagi Akifumi, Hoshi Seiji, Hata Junya, Ito Hiromi, Shimura Hiroki, Kojima Yoshiyuki, Nishita Michiru